Redeye regards I-Tech as fairly valued on the back of a Q1-report somewhat weaker than we had expected. Following a strong run in the share, we believe the market has discounted mild Corona Virus effects, now trading above our current fair value. We remain positive to the company's progress, with largely unchanged estimates, implying a strong outlook for sales and earnings in the coming years.

Read more and download the research update: https://bit.ly/2zB9hKy

Start following companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/

https://news.cision.com/i-tech/r/redeye--i-tech-exciting-time-ahead,c3112858

(c) 2020 Cision. All rights reserved., source Press Releases - English